IMRAN AHMAD

Dr. IMRAN AHMAD

USM
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FAFahmida Alam
Fahmida Alam
Md Asiful IslamMd Asiful Islam
Md Asiful Islam
MMMafauzy Mohamed
Mafauzy Mohamed
IAIMRAN AHMAD
IMRAN AHMAD
Mohammad KamalMohammad Kamal
Mohammad Kamal
MIMd Asiful Islam
Md Asiful Islam
Pioglitazone, the only thiazolidinedione drug in clinical practice is under scrutiny due to reported adverse effects, it’s unique insulin sensitising action provides rationale to remain as a therapeutic option for managing type 2 diabetes mellitus (T2DM). We conducted a systematic review and meta-analysis comparing pioglitazone monotherapy with monotherapies of other oral antidiabetic drugs for assessing its efficacy and safety in T2DM patients. Mean changes in glycated haemoglobin (HbA1c), and mean changes in fasting blood sugar (FBS) level, body weight (BW) and homeostasis model assessment-insulin resistance (HOMA-IR) were primary and secondary outcomes, respectively. Safety outcomes were changes in lipid parameters, blood pressure and incidences of adverse events. Metafor package of R software and RevMan software based on random-effects model were used for analyses. We included 16 randomised controlled trials. Pioglitazone monotherapy showed equivalent efficacy as comparators in reducing HbA1c by 0.05% (95% CI: −0.21 to 0.11) and greater efficacy in reducing FBS level by 0.24 mmol/l (95% CI: −0.48 to −0.01). Pioglitazone showed similar efficacy as comparators in reducing HOMA-IR (WMD: 0.05, 95% CI: −0.49 to 0.59) and increasing high-density lipoprotein level (WMD: 0.02 mmol/l, 95% CI: −0.06 to 0.10). Improved blood pressure (WMD: −1.05 mmHg, 95% CI: −4.29 to 2.19) and triglycerides level (WMD: −0.71 mmol/l, 95% CI: −1.70 to 0.28) were also observed with pioglitazone monotherapy. There was a significant association of pioglitazone with increased BW (WMD: 2.06 kg, 95% CI: 1.11 to 3.01) and risk of oedema (RR: 2.21, 95% CI: 1.48 to 3.31), though the risk of hypoglycaemia was absolutely lower (RR: 0.51, 95% CI: 0.33 to 0.80). Meta-analysis supported pioglitazone as an effective treatment option for T2DM patients to ameliorate hyperglycaemia, adverse lipid metabolism and blood pressure. Pioglitazone is suggested to prescribe following individual patient’s needs. It can be a choice of drug for insulin resistant T2DM patients having dyslipidaemia, hypertension or history of cardiovascular disease.

11 April 2007 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
RBRUZILAWATI ABU BAKAR
RUZILAWATI ABU BAKAR
MWMohd Suhaimi Abd. Wahab
Mohd Suhaimi Abd. Wahab
IAIMRAN AHMAD
IMRAN AHMAD
ZIZabidah Ismail
Zabidah Ismail
MIMd Asiful Islam
Md Asiful Islam

25 May 2016 in Journal of Psychoactive Drugs
Verified
Journal Article
Closed access
ADAlethea Desrosiers
Alethea Desrosiers
WCWeng-Tink Chooi
Weng-Tink Chooi
NZNorzarina Mohd Zaharim
Norzarina Mohd Zaharim
IAIMRAN AHMAD
IMRAN AHMAD
MYMohd Azhar Mohd Yasin
Mohd Azhar Mohd Yasin
MCMarek C. Chawarski
Marek C. Chawarski
The primarily rural and agrarian Kelantan province of Malaysia has high rates of drug use and is characterized by unique sociocultural factors. Combining qualitative and ethnographic methods, we investigated drug use and treatment needs of people who use drugs (PWUD) in rural areas of Kelantan. In February 2014, field visits, participant observation, and focus group discussions (FGDs) with 27 active PWUD were conducted in rural areas surrounding the capital city of Kelantan. The findings indicate a high prevalence of opiate and amphetamine type stimulants (ATS) use in these areas. FGD participants reported initiating drug use at early ages due to peer influences, to relieve boredom, to cope with problems, and a high saturation of villages with other PWUD was reported as a major contributor to their own continued drug use. They reported a trend of drug use initiation at younger ages and increased drug use among females. Participants were interested in treatment; however, their limited knowledge about treatment options and perceived limited availability of services were barriers to treatment seeking. Easy access to drugs, primarily from Thailand and facilitated by the use of mobile phones, resulted in an expanding prevalence of drug use that underscores the need to bolster education and prevention efforts and accessibility of treatment services in Kelantan.

29 June 2017 in Journal of Psychoactive Drugs
Verified
Journal Article
Closed access
WCWeng-Tink Chooi
Weng-Tink Chooi
NZNorzarina Mohd Zaharim
Norzarina Mohd Zaharim
ADAlethea Desrosiers
Alethea Desrosiers
IAIMRAN AHMAD
IMRAN AHMAD
MYMohd Azhar Mohd Yasin
Mohd Azhar Mohd Yasin
MCMarek C. Chawarski
Marek C. Chawarski
Amphetamine-type stimulants (ATS) use is increasingly prevalent in Malaysia, including among individuals who also use opioids. We evaluated cognitive functioning profiles among individuals with co-occurring opioid and ATS dependence and their lifetime patterns of drug use. Participants (N = 50) enrolling in a clinical trial of buprenorphine/naloxone treatment with or without atomoxetine completed the Raven’s Standard Progressive Matrices, Rey-Osterrieth Complex Figure Test, Digit Span, Trail Making and Symbol Digit Substitution tasks. Multidimensional scaling and a K-means cluster analyses were conducted to classify participants into lower versus higher cognitive performance groups. Subsequently, analyses of variance procedures were conducted to evaluate between group differences on drug use history and demographics. Two clusters of individuals with distinct profiles of cognitive performance were identified. The age of ATS use initiation, controlling for the overall duration of drug use, was significantly earlier in the lower than in the higher cognitive performance cluster: 20.9 (95% CI: 18.0–23.8) versus 25.2 (95% CI: 22.4–28.0, p = 0.038). While adverse effects of ATS use on cognitive functioning can be particularly pronounced with younger age, potentially related to greater vulnerability of the developing brain to stimulant and/or neurotoxic effects of these drugs, the current study findings cannot preclude lowered cognitive performance before initiation of ATS use.

30 August 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
CNChe Ismail Che Noh
Che Ismail Che Noh
IAIMRAN AHMAD
IMRAN AHMAD
SSSiti Suraiya
Siti Suraiya
NMNurfadhlina Musa
Nurfadhlina Musa
asma abdullah nurulasma abdullah nurul
asma abdullah nurul
RBRUZILAWATI ABU BAKAR
RUZILAWATI ABU BAKAR
Cytokines play an important role in modulating inflammation during viral infection, including hepatitis C virus (HCV) infection. Genetic polymorphisms of cytokines can alter the immune response against this infection. The objective of this study was to investigate the possible association between chronic hepatitis C virus infection susceptibility and cytokine gene polymorphism for interleukin-10 (IL-10) rs1800896 and rs1800871, interleukin 6 (IL-6) rs1800795, TNF-α rs1800629, and TGF-β1 rs1800471 in Malay male drug abusers. The study was conducted on 76 HCV-positive (HP) male drug abusers and 40 controls (HCV-negative male drug abusers). We found that there were significant differences in the frequencies of genotype for IL-10 rs1800871 (p = 0.0386) and at the allelic level for IL-10 rs1800896 A versus G allele (p = 0.0142) between the HP group and the control group. However, there were no significant differences in gene polymorphism in interleukin 6 rs1800795, TNF-α rs1800629 and TGF-β1 rs1800471. These findings suggest significant associations between gene polymorphism for IL-10 rs1800871, IL-10 rs1800896 (at the allelic level) and susceptibility to HCV infection among Malay male drug abusers.

1 May 2018 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
RSRichard S. Schottenfeld
Richard S. Schottenfeld
MCMarek C. Chawarski
Marek C. Chawarski
MSMehmet Sofuoglu
Mehmet Sofuoglu
WCWeng-Tink Chooi
Weng-Tink Chooi
NZNorzarina M. Zaharim
Norzarina M. Zaharim
BVB. Kasinather Vicknasingam
B. Kasinather Vicknasingam